KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target
Abstract
Blockade of KIR3DL3 is an immunotherapy for human cancers.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jul 29, 2021
- Source ID
- 10.1126/sciimmunol.abf9792
Entities
People
- Bijan Etemad-Gilbertson
- Deyou Zheng
- Fangxia Guan
- Hao Wang
- Jordan M. Chinai
- Lei Shi
- Lin Qi
- Liqiang Zhu
- Mou Peng
- Phillip M Galbo
- R. Alejandro Sica
- Scott Moerdler
- Xiaoxin Ren
- Xingxing Zang
- Xu-Dong Tang
- Yao Wei
Organizations
- Albert Einstein College of Medicine
- Montefiore Medical Center
- National Institutes of Health
- United States Department of Defense